Cinnamomum burmannii Bioactives as VEGFR-2 Inhibitors in Colon Cancer: A Chemoinformatics Approach

Colon cancer is among the most prevalent cancers globally, with its progression closely associated with angiogenesis, primarily mediated by the activation of vascular endothelial growth factor receptor 2 (VEGFR-2). Although VEGFR-2 inhibitors such as apatinib have demonstrated efficacy in colon cancer therapy, their clinical use is limited due to potential side effects and high treatment costs. Natural compounds from Cinnamomum burmannii, which are known to contain secondary metabolites including flavonoids, saponins, phenols, tannins, and sterols/triterpenoids, present a potential alternative. This study aims to evaluate the inhibitory potential of C. burmannii bioactive compounds against VEGFR-2 using a computational-based approach. The methodology involved Lipinski's rule of five (RO5) analysis, ADMET (absorption, distribution, metabolism, excretion, and toxicity) prediction, pharmacophore screening, and molecular docking simulations. Among the screened compounds, methylhydroxychalcone emerged as the most promising candidate, exhibiting a favorable binding affinity with a Gibbs free energy of −8.51 kcal/mol and an inhibition constant of 579.80 nM. It also fulfilled drug-likeness criteria and displayed a good pharmacokinetic profile. Notably, methylhydroxychalcone interacted with the Asp1046 residue on VEGFR-2, a key interaction site also targeted by Apatinib. These findings support the potential of cinnamon bark-derived compounds, particularly methylhydroxychalcone, as prospective VEGFR-2 inhibitors for colon cancer therapy.

Authors

Publication Details

Journal
Jurnal Riseta Naturafarm
Published
2026-11-13
DOI
https://doi.org/10.70392/jrn.v3i2.32
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Cinnamomum burmannii Bioactives as VEGFR-2 Inhibitors in Colon Cancer: A Chemoinformatics Approach

Dedy Ismail, Bintang Satrio Mahardika, Yasmine Ulayya Dhiya Iskandar, Dhania Novitasari et al.
Jurnal Riseta Naturafarm
Computational Drug Discovery Methods
article

Cinnamomum burmannii Bioactives as VEGFR-2 Inhibitors in Colon Cancer: A Chemoinformatics Approach

Dedy Ismail, Bintang Satrio Mahardika, Yasmine Ulayya Dhiya Iskandar, Dhania Novitasari, Nabilah Azzahra Frianjani, Zahra Aulia
article en

Abstract

Colon cancer is among the most prevalent cancers globally, with its progression closely associated with angiogenesis, primarily mediated by the activation of vascular endothelial growth factor receptor 2 (VEGFR-2). Although VEGFR-2 inhibitors such as apatinib have demonstrated efficacy in colon cancer therapy, their clinical use is limited due to potential side effects and high treatment costs. Natural compounds from Cinnamomum burmannii, which are known to contain secondary metabolites including flavonoids, saponins, phenols, tannins, and sterols/triterpenoids, present a potential alternative. This study aims to evaluate the inhibitory potential of C. burmannii bioactive compounds against VEGFR-2 using a computational-based approach. The methodology involved Lipinski's rule of five (RO5) analysis, ADMET (absorption, distribution, metabolism, excretion, and toxicity) prediction, pharmacophore screening, and molecular docking simulations. Among the screened compounds, methylhydroxychalcone emerged as the most promising candidate, exhibiting a favorable binding affinity with a Gibbs free energy of −8.51 kcal/mol and an inhibition constant of 579.80 nM. It also fulfilled drug-likeness criteria and displayed a good pharmacokinetic profile. Notably, methylhydroxychalcone interacted with the Asp1046 residue on VEGFR-2, a key interaction site also targeted by Apatinib. These findings support the potential of cinnamon bark-derived compounds, particularly methylhydroxychalcone, as prospective VEGFR-2 inhibitors for colon cancer therapy.

Jurnal Riseta NaturafarmVol. 3(2)
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon